Načítá se...
Cognitive effects of hormone therapy continuation or discontinuation in a sample of women at risk for Alzheimer’s disease
Use of estrogen-based hormone therapy (HT), as a protection from cognitive decline and Alzheimer’s disease, is controversial although cumulative data supports HT use when initiated close to menopause onset with estrogen formulations containing 17β-estradiol (17β-E) being preferable to conjugated equ...
Uloženo v:
| Vydáno v: | Am J Geriatr Psychiatry |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4654994/ https://ncbi.nlm.nih.gov/pubmed/26209223 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jagp.2015.05.009 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|